Skip to main content
Top
Published in: Sleep and Breathing 3/2015

01-09-2015 | Original Article

Lymphocytes from intermittent hypoxia-exposed rats increase the apoptotic signals in endothelial cells via oxidative and inflammatory injury in vitro

Authors: Hengjuan Guo, Jie Cao, Jinna Li, Xiaoyan Yang, Junnan Jiang, Jing Feng, Shuo Li, Jing Zhang, Baoyuan Chen

Published in: Sleep and Breathing | Issue 3/2015

Login to get access

Abstract

Objective

Obstructive sleep apnea (OSA) has been implicated as a risk factor for atherosclerosis. Intermittent hypoxia (IH) induces oxidative and immuno-inflammatory alterations that could contribute to atherosclerosis. The aim of this study was to examine the effect of lymphocytes from intermittent hypoxia-exposed rats on the apoptotic signals in endothelial cells and the interventional role of tempol.

Method

Male Wistar rats were randomly distributed into three groups (n = 8 each): control group, IH group, and tempol group (exposed to IH and treated with tempol). Lymphocytes isolated from the rats were coincubated subsequently with endothelial cells under normoxia or IH condition. We analyzed endothelial apoptosis-related proteins (Bcl-2, Bax, and caspase-3) by Western blotting and measured the marks of oxidative stress (MDA, SOD, and CAT) and inflammation (TNF-α, IL-8, CRP, and ICAM-1) in cocultural supernatants by ELISA. We also determined endothelial p22phox, c-fos, and HIF-1α messenger RNA (mRNA) expressions using real time PCR.

Results

A significant decrease in the Bcl-2 level and the Bcl-2/Bax ratio and a significant increase in Bax and caspase-3 levels in endothelial cells were observed when coincubated normoxically with lymphocytes from IH-exposed rats compared to control (P < 0.01). Moreover, the oxidative stress, inflammation, and mRNA expressions of endothelial p22phox, c-fos, and HIF-1α were elevated significantly (P < 0.01). The alterations induced by lymphocytes were partially restored by tempol pretreatment while exacerbated by intermittent hypoxic coincubation.

Conclusions

Lymphocytes from intermittent hypoxia-exposed rats increased the apoptotic signals in endothelial cells via oxidative and inflammatory injury in vitro, which could be attenuated by tempol.
Literature
1.
go back to reference Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071–1078PubMedCentralPubMed Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071–1078PubMedCentralPubMed
2.
go back to reference Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261–269CrossRefPubMed Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261–269CrossRefPubMed
3.
go back to reference Feng J, Chen BY, Cui LY, Wang BL, Liu CX, Chen PF, Guo MN, Dong LX, Li S (2009) Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin. Sleep Breath 13:277–283CrossRefPubMed Feng J, Chen BY, Cui LY, Wang BL, Liu CX, Chen PF, Guo MN, Dong LX, Li S (2009) Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin. Sleep Breath 13:277–283CrossRefPubMed
4.
go back to reference Khayat R, Patt B, Hayes D Jr (2009) Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Fail Rev 14:143–153PubMedCentralCrossRefPubMed Khayat R, Patt B, Hayes D Jr (2009) Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Fail Rev 14:143–153PubMedCentralCrossRefPubMed
5.
go back to reference Choy J, Granville D, Hunt D, McManus B (2001) Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33:1673–1690CrossRefPubMed Choy J, Granville D, Hunt D, McManus B (2001) Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33:1673–1690CrossRefPubMed
6.
go back to reference Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101:2450–2453CrossRefPubMed Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101:2450–2453CrossRefPubMed
7.
go back to reference Arnaud C, Dematteis M, Pépin JL, Baguet JP, Lévy P (2009) Obstructive sleep apnea syndrome, immuno-inflammation and atherosclerosis. Semin Immunopathol 31:113–125PubMedCentralCrossRefPubMed Arnaud C, Dematteis M, Pépin JL, Baguet JP, Lévy P (2009) Obstructive sleep apnea syndrome, immuno-inflammation and atherosclerosis. Semin Immunopathol 31:113–125PubMedCentralCrossRefPubMed
8.
go back to reference Dyugovskaya L, Lavie P, Lavie L (2005) Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann NY Acad Sci 1051:340–350CrossRefPubMed Dyugovskaya L, Lavie P, Lavie L (2005) Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann NY Acad Sci 1051:340–350CrossRefPubMed
9.
go back to reference Dyugovskaya L, Lavie P, Hirsh M, Lavie L (2005) Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25:820–828CrossRefPubMed Dyugovskaya L, Lavie P, Hirsh M, Lavie L (2005) Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25:820–828CrossRefPubMed
10.
go back to reference Dyugovskaya L, Lavie P, Lavie L (2003) Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168:242–249CrossRefPubMed Dyugovskaya L, Lavie P, Lavie L (2003) Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168:242–249CrossRefPubMed
11.
go back to reference Williams RJ, Motteram JM, Sharp CH, Gallagher PJ (1992) Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94:153–159CrossRefPubMed Williams RJ, Motteram JM, Sharp CH, Gallagher PJ (1992) Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94:153–159CrossRefPubMed
12.
go back to reference Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 84:5928–5931PubMedCentralCrossRefPubMed Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 84:5928–5931PubMedCentralCrossRefPubMed
13.
go back to reference Cannizzo B, Quesada I, Militello R, Amaya C, Miatello R, Cruzado M, Castro C (2014) Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression. Free Radic Res 48:526–533CrossRefPubMed Cannizzo B, Quesada I, Militello R, Amaya C, Miatello R, Cruzado M, Castro C (2014) Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression. Free Radic Res 48:526–533CrossRefPubMed
14.
go back to reference Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167:6140–6149CrossRefPubMed Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167:6140–6149CrossRefPubMed
15.
go back to reference Zhou W, Wan N, Zhang Z, Guo R, Chen B (2012) Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues. Respirology 17:821–829CrossRefPubMed Zhou W, Wan N, Zhang Z, Guo R, Chen B (2012) Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues. Respirology 17:821–829CrossRefPubMed
16.
go back to reference He Q, Yang QC, Zhou Q, Zhu H, Niu WY, Feng J, Wang Y, Cao J, Chen BY (2014) Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3 T3-L1 adipocytes. PLoS One 9:e86326PubMedCentralCrossRefPubMed He Q, Yang QC, Zhou Q, Zhu H, Niu WY, Feng J, Wang Y, Cao J, Chen BY (2014) Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3 T3-L1 adipocytes. PLoS One 9:e86326PubMedCentralCrossRefPubMed
17.
go back to reference Bauriedel G, Hutter R, Welsch U, Bach R, Sievert H, Lüderitz B (1999) Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 41:480–488CrossRefPubMed Bauriedel G, Hutter R, Welsch U, Bach R, Sievert H, Lüderitz B (1999) Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 41:480–488CrossRefPubMed
18.
go back to reference Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed
19.
go back to reference Chen F, Qian LH, Deng B, Liu ZM, Zhao Y, Le YY (2013) Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress. CNS Neurosci Ther 19:675–681CrossRefPubMed Chen F, Qian LH, Deng B, Liu ZM, Zhao Y, Le YY (2013) Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress. CNS Neurosci Ther 19:675–681CrossRefPubMed
20.
go back to reference Fu R, Wang Q, Guo Q, Xu J, Wu X (2013) XJP-1 protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by inhibiting NADPH oxidase subunit expression and modulating the PI3K/Akt/eNOS pathway. Vascul Pharmacol 58:78–86CrossRefPubMed Fu R, Wang Q, Guo Q, Xu J, Wu X (2013) XJP-1 protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by inhibiting NADPH oxidase subunit expression and modulating the PI3K/Akt/eNOS pathway. Vascul Pharmacol 58:78–86CrossRefPubMed
21.
go back to reference Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804CrossRefPubMed Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804CrossRefPubMed
22.
go back to reference Spillmann F, Van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP, Tschöpe C (2014) LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol- modulating effects. Atherosclerosis 232:1–9CrossRefPubMed Spillmann F, Van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP, Tschöpe C (2014) LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol- modulating effects. Atherosclerosis 232:1–9CrossRefPubMed
23.
go back to reference Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51CrossRefPubMed Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51CrossRefPubMed
24.
go back to reference Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462–466CrossRefPubMed Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462–466CrossRefPubMed
25.
go back to reference Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196:129–135CrossRefPubMed Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196:129–135CrossRefPubMed
26.
go back to reference Zhang S, Zhao Y, Xu M, Yu L, Zhao Y, Chen J, Yuan Y, Zheng Q, Niu X (2013) FoxO3a modulates hypoxia stress induced oxidative stress and apoptosis in cardiac microvascular endothelial cells. PLoS One 8:e80342PubMedCentralCrossRefPubMed Zhang S, Zhao Y, Xu M, Yu L, Zhao Y, Chen J, Yuan Y, Zheng Q, Niu X (2013) FoxO3a modulates hypoxia stress induced oxidative stress and apoptosis in cardiac microvascular endothelial cells. PLoS One 8:e80342PubMedCentralCrossRefPubMed
27.
go back to reference Zhu J, Rebecchi MJ, Wang Q, Glass PS, Brink PR, Liu L (2013) Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart. Am J Physiol Heart Circ Physiol 304:H649–H659CrossRefPubMed Zhu J, Rebecchi MJ, Wang Q, Glass PS, Brink PR, Liu L (2013) Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart. Am J Physiol Heart Circ Physiol 304:H649–H659CrossRefPubMed
28.
go back to reference Lavie L (2012) Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci 4:1391–1403CrossRef Lavie L (2012) Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci 4:1391–1403CrossRef
29.
go back to reference Yang YY, Shang J, Liu HG (2013) Role of endoplasmic reticular stress in aortic endothelial apoptosis induced by intermittent/persistent hypoxia. Chin Med J 126:4517–4523PubMed Yang YY, Shang J, Liu HG (2013) Role of endoplasmic reticular stress in aortic endothelial apoptosis induced by intermittent/persistent hypoxia. Chin Med J 126:4517–4523PubMed
Metadata
Title
Lymphocytes from intermittent hypoxia-exposed rats increase the apoptotic signals in endothelial cells via oxidative and inflammatory injury in vitro
Authors
Hengjuan Guo
Jie Cao
Jinna Li
Xiaoyan Yang
Junnan Jiang
Jing Feng
Shuo Li
Jing Zhang
Baoyuan Chen
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1128-8

Other articles of this Issue 3/2015

Sleep and Breathing 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.